SAB Biotherapeutics (SABS) Capital Leases (2020 - 2026)
SAB Biotherapeutics (SABS) recorded Capital Leases of $3.04 million in Q2 2026, down 5.0% from $3.2 million a year earlier and down 1.3% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Capital Leases (2020 - 2026) Analysis & Trends
At the end of FY2025, SAB Biotherapeutics reported Capital Leases of $3.12 million, down 4.7% from FY2024.
- Annual Capital Leases has declined for five straight years, with a five-year compound annual growth rate of -4.5% (FY2020 to FY2025).
- Across earlier years, Capital Leases came in at $3.28 million in FY2024 (-4.2%), $3.42 million in FY2023 (-5.8%), $3.63 million in FY2022 (-3.5%) and $3.76 million in FY2021 (-4.1%).
- The Q2 2026 figure is the lowest quarterly Capital Leases in data going back to Q4 2020.
- On a year-over-year basis, Capital Leases has declined for 15 consecutive quarters, with an average decline of 4.5% over the last eight quarters.
- Over the past five years, the year-over-year decline in Capital Leases ranged from 3.5% (Q4 2022) to 5.9% (Q1 2024).
- Per Business Quant, the preceding three quarters came in at $3.08 million (Q1 2026), $3.12 million (Q4 2025) and $3.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.80 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 614.95 Bn | 533.47 Bn | 17.26 Bn |
| 3 | AbbVie | 505.05 Bn | 478.16 Bn | 12.70 Bn |
| 4 | Merck | 368.08 Bn | 322.46 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.32 Bn | 262.31 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.58 Bn | 235.26 Bn | 12.86 Bn |
| 7 | Amgen | 236.05 Bn | 191.45 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.61 Bn | 164.80 Bn | 6.22 Bn |
| 9 | Pfizer | 169.86 Bn | 116.50 Bn | 10.94 Bn |
| 10 | SAB Biotherapeutics | 228.29 Mn | -189.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.04 Mn |
| Mar 31, 2026 | 3.08 Mn |
| Dec 31, 2025 | 3.12 Mn |
| Sep 30, 2025 | 3.16 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 3.24 Mn |
| Dec 31, 2024 | 3.28 Mn |
| Sep 30, 2024 | 3.31 Mn |
| Jun 30, 2024 | 3.35 Mn |
| Mar 31, 2024 | 3.38 Mn |
| Dec 31, 2023 | 3.42 Mn |
| Sep 30, 2023 | 3.45 Mn |
| Jun 30, 2023 | 3.49 Mn |
| Mar 31, 2023 | 3.60 Mn |
| Dec 31, 2022 | 3.63 Mn |
| Sep 30, 2022 | 3.66 Mn |
| Jun 30, 2022 | 3.69 Mn |
| Mar 31, 2022 | 3.73 Mn |
| Dec 31, 2021 | 3.76 Mn |
| Dec 31, 2020 | 3.92 Mn |
API Access
SAB Biotherapeutics Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();